No abstract available
MeSH terms
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacokinetics
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology*
-
Animals
-
Brain / drug effects*
-
Brain / physiopathology
-
Calcium / physiology*
-
Calcium Channels / drug effects
-
Calcium Channels / physiology
-
Cell Death / drug effects
-
Cell Death / physiology
-
Corpus Striatum / drug effects
-
Corpus Striatum / physiopathology
-
Dopamine / metabolism*
-
Free Radicals
-
Hydroxides / metabolism*
-
Hydroxyl Radical
-
Iron / physiology
-
Monoamine Oxidase / physiology
-
Nerve Degeneration / drug effects
-
Nerve Degeneration / physiology
-
Neural Pathways / drug effects
-
Neural Pathways / physiopathology
-
Oxidation-Reduction
-
Parkinson Disease, Secondary / chemically induced*
-
Parkinson Disease, Secondary / physiopathology
-
Potassium / physiology
-
Potassium Channels / drug effects
-
Potassium Channels / physiology
-
Rats
-
Substantia Nigra / drug effects*
-
Substantia Nigra / physiopathology
Substances
-
Calcium Channels
-
Free Radicals
-
Hydroxides
-
Potassium Channels
-
Hydroxyl Radical
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
-
Iron
-
Monoamine Oxidase
-
Potassium
-
Calcium
-
Dopamine